PDK1 and type 1 diabetes mellitus: The underlying mechanism by which FoxO1 pharmacological inhibition reverses the progression of vascular remodelling in T1DM rats includes the activation of PDK1/FoxO1 pathway and the decrease in FoxO1 nuclear translocation.